CD44 and breast cancer: In this work, with the aim to combine the CD44-targeting ability of HA and the redox-responsivity of cystamine (cys), we develop a nanoparticle system (FNPs) via ionic complexation at physiological pH of cysHSA derivative and HA for doxorubicin (DOX) vectorization in breast cancer cell lines.